Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessDengue

Clinical and Analytical Performance of the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit

Viruses·

Valentina Hjelt, Agustina Dronseck, Aldana Magalí Schey, María Belén Martí, Luciano Civerchia, Ana Laura Cavatorta, Eduardo Codino, Virginia Nader, Natalia Andrea Garro, Federico Manuel Aranda, Lilia Mammana, Sergio Giamperetti, Clara Theaux, Anisa Marchissio, Valeria Estefanía Burani, Erica Natalia Luczak, María Martina Bellucci, Gabriela García, Florencia Cayrol, María Belén Bouzas, Sergio Grutadauria, Lucila Brocardo

DOI
10.3390/v18080914
PMID
PMCID
OpenAlex
Study type
Journal article
Publisher
MDPI AG
Article type
journal-article
Integrity
current

Why this research matters now

A sensitive and specific RT-PCR assay for early dengue detection across all four serotypes may support clinical diagnosis and epidemiologic surveillance, particularly in endemic tropical and subtropical regions with rising incidence.

01

Structured evidence summary

Research question

The study evaluated the clinical and analytical performance of a real-time RT-PCR kit for detecting dengue virus RNA across the four serotypes in human serum and plasma.

Study design

A diagnostic accuracy and analytical validation study using previously characterized serum and plasma specimens, with reproducibility assessed across three independent laboratories.

Population and setting

A total of 296 serum and 221 plasma samples were analyzed, including 56 serotype-characterized positives (25 DENV-1 and 31 DENV-2). The setting is not described in the supplied abstract; the kit manufacturer is based in Argentina.

Main findings

Reported clinical sensitivity and specificity were 97.8% and 100.0% for serum, and 100.0% and 99.1% for plasma. The Limit of Detection was determined for all four serotypes. Additional findings included high inter-laboratory reproducibility, no cross-reactivity with other febrile pathogens, and no interference from endogenous or exogenous substances at clinical levels.

Public-health relevance

A sensitive and specific RT-PCR assay for early dengue detection across all four serotypes may support clinical diagnosis and epidemiologic surveillance, particularly in endemic tropical and subtropical regions with rising incidence.

Important limitations

This summary is limited to the supplied single-article abstract and metadata; no explicit limitations are stated in the abstract, and the full original paper is required for decision-grade interpretation.

GIDS interpretation

Within GIDS, this article is discoverable under the Dengue disease tag and the Diagnostics and Surveillance topic tags, with geographic linkage to Argentina, supporting retrieval by users searching for dengue diagnostic performance evidence.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 8 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseaddresses topicaddresses topicevaluates interventionhas pathogen typestudied population settingstudies pathogenuses study design